Literature DB >> 29303101

[Testosterone therapy: indications and risks].

M G F Maatje1, M Dinkelman-Smit, W P A Boellaard, G R Dohle.   

Abstract

- Late onset hypogonadism (LOH) is a shortage of testosterone in adult men whose male development was normal. This form of hypogonadism results in decreased testosterone levels and variable gonadotrophin levels. - The symptoms of LOH are often aspecific and may be consistent with ageing in men: lowered libido, loss of strength, reduced cognitive functioning and disorders of sleeping and mood. - There is discussion about testosterone parameters, but if clinical symptoms are consistent with LOH and the testosterone level is < 8 nmol/l, hypogonadism is evidently indicated. - The first step is giving advice on lifestyle and treating comorbidity. In addition, treatment with testosterone may be given. - Testosterone has a positive effect on sexual function and vitality. Testosterone therapy for hypogonadism decreases the risk of osteoporosis. Contraindications are advanced prostate cancer and the desire to have children. - If a patient is treated with testosterone, strict follow-up is recommended; testosterone, haematocrit and PSA levels should be determined at set intervals.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29303101

Source DB:  PubMed          Journal:  Ned Tijdschr Geneeskd        ISSN: 0028-2162


  1 in total

1.  H2 S catalysed by CBS regulates testosterone synthesis through affecting the sulfhydrylation of PDE.

Authors:  Jing Wang; Jing Wang; Tao Shen; Renyun Hong; Shanshan Tang; Xia Zhao
Journal:  J Cell Mol Med       Date:  2021-03-13       Impact factor: 5.295

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.